Tag: Pulsed field ablation
Cardiac Rhythm News’ top stories of 2024
From first-time clinical data to major industry debuts, here are Cardiac Rhythm News’ 10 most popular stories of 2024.
1. Abbott joins the pulsed field...
Pulse Biosciences announces presentation of late-breaking data on nsPFA 360-degree cardiac...
Pulse Biosciences has announced late-breaking data from the first-in-human feasibility study of its nanosecond pulsed field ablation (nsPFA) 360-degree cardiac catheter system at the...
Boston Scientific launches next generation of cardiac mapping for Farapulse PFA...
Boston Scientific Corporation has announced that it has received US Food and Drug Administration (FDA) approval of the navigation-enabled Farawave Nav ablation catheter for...
Pulse Biosciences successfully treats first patients with nano-PFA cardiac surgery system
Pulse Biosciences has announced treatment of the first two patients in a first-in-human feasibility study using its novel nanosecond pulsed field ablation (nsPFA) cardiac...
Advertorial: PFA is now “beyond the phase of excitement”
This advertorial is sponsored by Boston Scientific
The arrival of pulsed-field ablation (PFA) has been heralded by many experts in the field of arrhythmia management...
MANIFEST-17k registry shows promising safety performance for PFA
Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), findings of the largest real-world registry of the...
Biosense Webster submits premarket approval application to US FDA for Varipulse...
Biosense Webster has submitted a premarket approval application (PMA) to the US Food & Drug Administration (FDA) for its Varipulse platform. The submission was...
Varipulse PFA system receives CE mark
Biosense Webster has announced the receipt of European CE mark approval for the Varipulse platform for the treatment of symptomatic drug refractory recurrent paroxysmal...
Sixty-day follow-up “positive” among AF patients treated with CellFX pulsed field...
Pulse Biosciences has announced favourable findings from the 60-day post-procedure evaluations for four initial patients treated in the Company’s CellFX nanosecond pulsed field ablation...
Biosense Webster supports VIRTUE and POLARIS studies of Varipulse PFA system
Biosense Webster has announced support for two collaborative studies, VIRTUE and POLARIS aiming to better understand the use and workflows with the investigational Varipulse...
Boston Scientific’s Farapulse PFA system gains US FDA approval
Boston Scientific has received US Food and Drug Administration (FDA) approval for the Farapulse pulsed field ablation (PFA) system.
The Farapulse PFA system is indicated...
Varipulse PFA platform granted approval by Japanese Ministry of Health
Biosense Webster has today announced approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the Varipulse platform for the treatment of...
Medtronic’s PulseSelect PFA system gains US FDA approval
Medtronic has announced that the US Food and Drug Administration (FDA) has approved the PulseSelect pulsed field ablation (PFA) system for the treatment of...
Medtronic’s PulseSelect PFA system and Nitron CryoConsole gain CE mark
Medtronic has received CE mark for the PulseSelect pulsed field ablation (PFA) system and the Nitron CryoConsole.
The PulseSelect system is designed to treat atrial...
Advertorial: Milestone procedure underscores optimism for future of pulsed field ablation
This advertorial is sponsored by Boston Scientific
Physicians at Na Homolce Hospital (Prague, Czech Republic) have recently completed their 2,000th clinical case using the FARAPULSE...
HRS 2023: Late-breaking clinical trial results support PFA as treatment option...
New data from three late-breaking clinical trials has demonstrated the safety and efficacy of pulsed field ablation (PFA) as a viable, non-thermal treatment option...
First patients treated in Kardium PULSAR IDE study of Globe pulsed...
Kardium, a private medical device company that has developed the Globe pulsed field (PF) system for the treatment of atrial fibrillation (AF) using pulsed...
Medtronic receives CE Mark approval for Affera mapping and ablation system...
Medtronic has announced today that it has received CE Mark for the Affera mapping and ablation system, which includes the Sphere-9 catheter and the...
Medtronic completes enrolment in pulsed field ablation catheter trial for patients...
Medtronic has announced enrolment completion and final treatment in the SPHERE Per-AF, a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trial....
AF Symposium 2022: Latest evidence for lattice tip catheter ablation strategies...
Pulsed-field ablation (PFA) and/or radiofrequency ablation (RFA) using a lattice-tip catheter can both isolate pulmonary veins (PVs) and create linear lesions efficiently and safely,...
AF Symposium 2020: Myocardial specificity of pulsed field ablation provides safety...
At the AF Symposium 2020 (23–25 January, Washington, DC, USA), Vivek Y Reddy (Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, USA)...